U.S. Physical Therapy (NYSE:USPH - Get Free Report) had its price objective raised by analysts at Barrington Research from $98.00 to $103.00 in a report issued on Friday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Barrington Research's target price would suggest a potential upside of 23.40% from the stock's previous close.
Several other analysts have also recently issued reports on USPH. JMP Securities reissued a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.
Check Out Our Latest Research Report on USPH
U.S. Physical Therapy Price Performance
Shares of U.S. Physical Therapy stock opened at $83.47 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.19. The business's 50 day simple moving average is $76.14 and its two-hundred day simple moving average is $77.17. The stock has a market capitalization of $1.27 billion, a P/E ratio of 36.45, a price-to-earnings-growth ratio of 3.53 and a beta of 1.45.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.83%. The company had revenue of $197.34 million for the quarter, compared to the consensus estimate of $190.24 million. During the same period in the previous year, the firm earned $0.73 earnings per share. The firm's revenue for the quarter was up 18.0% on a year-over-year basis. Analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current year.
Insiders Place Their Bets
In other news, Director Nancy Ham sold 400 shares of the stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director owned 2,594 shares of the company's stock, valued at approximately $202,357.94. This represents a 13.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company's stock.
Hedge Funds Weigh In On U.S. Physical Therapy
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Assetmark Inc. increased its stake in shares of U.S. Physical Therapy by 35.7% in the 2nd quarter. Assetmark Inc. now owns 570 shares of the company's stock worth $45,000 after acquiring an additional 150 shares in the last quarter. Portside Wealth Group LLC lifted its holdings in shares of U.S. Physical Therapy by 3.9% during the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock valued at $297,000 after purchasing an additional 154 shares during the last quarter. Precision Wealth Strategies LLC boosted its position in shares of U.S. Physical Therapy by 6.6% in the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock worth $221,000 after purchasing an additional 189 shares in the last quarter. Aquatic Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after purchasing an additional 198 shares in the last quarter. Finally, Bessemer Group Inc. grew its stake in shares of U.S. Physical Therapy by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock worth $357,000 after buying an additional 208 shares during the last quarter.
U.S. Physical Therapy Company Profile
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.